Navigation Links
Unique case study on Alzheimer's disease
Date:12/14/2010

A case study from the Swedish medical university Karolinska Institutet sheds light on the pathological course of Alzheimer's disease. The brain of the first Alzheimer's patient to display amyloids demonstrable with a PET scanner has been studied, both during progression of the disease and after death.

One pathological characteristic of Alzheimer's disease is the accumulation in the brain of beta-amyloid proteins to form amyloid plaques. However, it is not known how early the plaques forms in the brain, whether they are the primary cause of the disease or what pathogenic role is played by other changes in the brain.

The very first PET scan in the world of amyloid plaque in a living patient with the amyloid-binding compound 11C-PIB was performed in 2002 by Professor Agneta Nordberg at Karolinska Institutet on a 56-year old Alzheimer's patient. The researchers then monitored the patient as the disease progressed with regular PET scans and memory tests. After the patient died, the team carried out pathological and neurochemical analyses of the brain tissue.

The combined result analyses, which are now published in the renowned neurological journal BRAIN, give a detailed picture of how Alzheimer's disease develops. For example, the results show that high concentrations of amyloid plaques were discovered at an early stage of the disease when the patient suffered slight memory loss. The levels remained unchanged during the course of the disease, in contrast to the increasingly declining energy metabolism in the brain, which was also measured using PET as the patient's memory gradually deteriorated.

One formerly unknown connection that was discovered in the study is that the greater accumulation of plaque is accompanied by a reduction in the number of neuronal nicotinic receptors in the brain. These receptors are central to memory function, and this new finding demonstrates that the receptors are affected early on in the disease development. Further, inflammatory changes were measured in brain regions with low levels of plaques, which suggest that the neuroinflammation related to Alzheimer's disease might have a different cause and evolve at different stage of the disease compared to that of amyloid accumulation. Studies on this are currently being carried out on living patients using PET technology.

Today, over 1,000 patients around the world have undergone PET scans for measuring amyloid concentrations in the brain. PIB-PET was recently recommended as the earliest clinical diagnostic biomarker for discovering Alzheimer's disease, following the diagnostic guidelines laid out by the American Alzheimer's Association. However, if clinicians are to gain further insight into the importance of these PET examinations, a follow up of the results obtained from conducted PET studies should be performed in the brain tissue of deceased patients.

"If we combine different examinations, we will be able to affirm that complex changes take place at the same time in the brain during the development of Alzheimer's disease", says Professor Nordberg. "Our study shows that new, modern imaging technology known as molecular imaging makes it possible to discover the disease at an early stage. This opens up new opportunities for early diagnosis and for understanding the causes of the disease and identifying patients who can be expected to respond well to future Alzheimer's therapy."


'/>"/>

Contact: Katarina Sternudd
katarina.sternudd@ki.se
46-852-483-895
Karolinska Institutet
Source:Eurekalert

Related medicine news :

1. Womens unique connection to nature is explored in special issue of Ecopsychology
2. OncologyPRO: Unique portal for cancer specialists
3. Unique gastroenterology procedure developed in adults shows promise in pediatrics
4. Hidden Pond Productions Announces a Unique One-Stop Shop of Music/Talent Supervisions, IP Licensing and Original Custom Music
5. Ergonomic HandShoe Mouse Publish Proof of Unique Difference with Competition
6. Home Gym Equipment Supplier, Fitness 4 Home Online, Features Unique Fitness Offerings
7. As Popularity of Dental Implants Rise, a Chicago Cosmetic Dentistry Practice's On-site Lab Offers Patients a Unique Incentive
8. Unique Marketing Approach to the Energy Drink Market Brings Explosive Response
9. Unique and Nutritious Vegetarian Recipes Featured in Newly Released Hand-Bag Friendly “A must have...The Maroema Cook Book”
10. UniqueU Medical Weight Loss Success Requires an Expansion and Move to a Larger Location
11. Unique Alzheimer's Program Improves Quality Of Life And Provides Purpose
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... Ongoing news ... Aging Life Care Association™ (ALCA) to conduct a survey that takes a closer look ... released today illustrates the prevalence and causes of TBI among the aging population, and ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... welcomes S.S. Nesbitt as the latest addition to its growing list of Partner ... locations throughout the Southeast, from Orlando to Huntsville and in between. , Harnessing ...
(Date:2/10/2016)... ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading ... the fourth quarter and full year ended December 31, 2015 on Monday, February 29, ... webcast for the investment community following the release at 4:30 PM ET. Investors interested ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The Association ... inspirational speaker Jan Fox will serve as keynote speaker at the organization’s 2016 ... with tools to more effectively communicate with their own organizational staff and leadership. ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact Phyllis Strupp 480-488-5858 , ... with Age: The Ultimate Guide to Brain Training" by award-winning author Phyllis Strupp ... publication date is March 16, 2016. A free review copy is available to ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 9, 2016 On Tuesday, February ... met with its Arthritis Advisory Committee to ... Johnson & Johnson,s Remicade and most likely ... the U.S. The Biologics Prescribers Collaborative (BPC) ... Alliance for Patient Access, American Association of ...
(Date:2/10/2016)... February 10, 2016 The campaign aims ... 5 years reach the milestone of their 5 th ... ensure 2,50,532 children between the ages of 2 - 5 ... --> The campaign aims to ... reach the milestone of their 5 th birthday   ...
(Date:2/9/2016)... FARMINGDALE, N.Y., Feb. 9, 2016  Misonix, Inc. ... company that designs, manufactures and markets innovative therapeutic ... wound debridement, cosmetic surgery, laparoscopic surgery and other ... second quarter and the first half of fiscal ... --> --> Highlights ...
Breaking Medicine Technology: